Several red flags here. Studies and reagent development due for completion in 2019. I realise it's out of their control now, but clinical trial recruitment could be suspended indefinitely. And yet - still no communication from the company. This is extremely poor management. For those who have corresponded with the CEO, has there been any explanation why they are refusing to update the market ?
Lack of communication
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
